Related Experiment Video

Updated: Jul 15, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis

M Thangarajh1, L Kisiswa, R Pirskanen

  • 1Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital at Huddinge, Stockholm, Sweden. mathula.thangarajh@ki.se

Scandinavian Journal of Immunology
|April 21, 2007
PubMed

Insights

B-cell activating factor (BAFF) receptors are not altered in multiple sclerosis (MS) or myasthenia gravis (MG). This study found no significant differences in BAFF-binding receptor expression on lymphocytes in patients with MS or MG compared to healthy individuals.

Area of Science:

  • Immunology
  • Neuroimmunology
  • Cell Biology

Background:

  • Multiple sclerosis (MS) involves central nervous system myelin injury, with antibody-mediated oligodendrocyte death in some cases.
  • Myasthenia gravis (MG) is characterized by autoantibodies destroying acetylcholine receptors at the neuromuscular junction.
  • B-cell activating factor (BAFF) is crucial for B-cell survival and implicated in autoimmune diseases.

Purpose of the Study:

  • To investigate the expression of BAFF-binding receptors (BAFF-R, BCMA, TACI) on peripheral blood lymphocytes in MS and MG patients.
  • To compare receptor expression levels between patients with MS or MG and healthy controls.

Main Methods:

  • Flow cytometry was used to analyze the expression of BAFF-R, BCMA, and TACI on B cells and T cells.
  • Peripheral blood lymphocytes from MS patients, MG patients, and healthy controls were analyzed.

Main Results:

  • BAFF-receptor (BAFF-R) was highly expressed on B cells (CD19+) and memory B cells (CD19+CD27+), with no significant difference in intensity between MS, MG, and controls.
  • BCMA was exclusively expressed on B cells, and TACI was expressed on both B and T cells, with higher levels on B cells.
  • The percentages of B and T cells expressing BCMA and TACI showed no significant differences between MS/MG patients and controls.

Conclusions:

  • The expression of BAFF-binding receptors (BAFF-R, BCMA, TACI) on peripheral blood lymphocytes is not significantly altered in multiple sclerosis or myasthenia gravis.
  • These findings suggest that alterations in BAFF-binding receptor expression are unlikely to be a primary driver in the pathogenesis of MS or MG.

More Related Videos

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...